COST-EFFECTIVENESS OF INSULIN DETEMIR IN PEOPLE WITH TYPE 2 DIABETES IN ROMANIA

被引：0
|
作者：
Ionescu-Targoviste, C. [1 ]
Wrona, W. [2 ]
Schubert, A. [3 ]
Niewada, M. [2 ]
Czech, M. [3 ]
机构：
[1] Natl Inst Diabet Nicolae Paulescu, Bucharest, Romania
[2] HealthQuest Sp Zoo Spk, Warsaw, Poland
[3] Novo Nordisk Pharma Sp Zoo, Warsaw, Poland
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1681
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A500 / A500
页数：1
相关论文
共 50 条
  • [1] An analysis of the cost-effectiveness of starting insulin detemir in insulin-naive people with type 2 diabetes
    Home, Philip
    Baik, Sei Hyun
    Gonzalez Galvez, Guillermo
    Malek, Rachid
    Nikolajsen, Annie
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (03) : 230 - 240
  • [2] Cost-Effectiveness of Insulin Detemir and Insulin Aspart in People with Type 1 Diabetes Prone to Recurrent Severe Hypoglycaemia
    Pedersen-Bjergaard, Ulrik
    Kristensen, Peter Lommer
    Norgaard, Kirsten
    Perrild, Hans
    Jensen, Tonny
    Thorsteinsson, Birger
    Nikolajsen, Annie
    Tarnow, Lise
    [J]. DIABETES, 2015, 64 : A348 - A348
  • [3] SHORT AND LONG-TERM COST-EFFECTIVENESS OF SWITCHING THERAPY FROM INSULIN GLARGINE TO INSULIN DETEMIR IN PEOPLE WITH TYPE 2 DIABETES
    Malek, R.
    Galvez, G. G.
    Hammerby, E.
    Nikolajsen, A.
    Henriksen, O.
    Andersen, M. F. B.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A690 - A690
  • [4] Cost-effectiveness analysis of insulin detemir compared to NPH insulin in patients with type-2 diabetes in the United Kingdom
    Smith, I
    Palmer, AJ
    Roze, S
    Kennedy-Martin, T
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 735 - 736
  • [5] Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer's perspective
    Permsuwan, Unchalee
    Thavorn, Kednapa
    Dilokthornsakul, Piyameth
    Saokaew, Surasak
    Chaiyakunapruk, Nathorn
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (09) : 991 - 999
  • [6] Cost-effectiveness of insulin detemir: a systematic review
    Suh, Dong-Churl
    Aagren, Mark
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (06) : 641 - 655
  • [7] Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands
    Roze, S.
    Duteil, E.
    Smith-Palmer, J.
    de Portu, S.
    Valentine, W.
    de Brouwer, B. F. E.
    Reznik, Y.
    de Valk, H. W.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (08) : 742 - 749
  • [8] Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemia
    Pedersen-Bjergaard, Ulrik
    Kristensen, Peter Lommer
    Norgaard, Kirsten
    Perrild, Hans
    Jensen, Tonny
    Thorsteinsson, Birger
    Nikolajsen, Annie
    Tarnow, Lise
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (10) : 1719 - 1725
  • [9] Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis
    Tunis, Sandra L.
    Minshall, Michael E.
    Conner, Christopher
    McCormick, John I.
    Kapor, Jovana
    Yale, Jean-Francois
    Groleau, Danielle
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (05) : 1273 - 1284
  • [10] COST-EFFECTIVENESS OF USING DETEMIR IN TYPE 2 DIABETES WITH THE RISK OF CARDIOVASCULAR EVENTS AND DEATH
    Romero, M.
    Chavez, D.
    Karpf, E.
    Alvis, N.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A547 - A547
12345